Journal of Cellular and Molecular Medicine 2023

9 papers
The 2023 edition of the Journal of Cellular and Molecular Medicine featured research focused on oncology, pulmonary pathology, and molecular signaling pathways. A significant portion of the published work investigated therapeutic interventions for various cancers, including the use of melatonin to enhance cisplatin effects and the application of the antimicrobial peptide M1-8 to induce apoptosis in liver cancer cells. Other studies explored the role of WHSC1 in hepatocellular carcinoma progression, specifically its involvement in DNA damage and cellular senescence. Research also addressed fibrotic and inflammatory conditions, such as the use of Duvelisib to attenuate pulmonary fibrosis via the PI3K/Akt/mTOR pathway and the role of emetine dihydrochloride in mitigating radiation-induced lung injury. Additionally, the year's publications covered physiological topics like ion channel regulation of nutrient absorption and the identification of circANRIL as a potential transcriptional biomarker for coronary artery disease. Notable contributors to this year's volume included authors such as Chun-Ting Li, Kailun He, and Jian Wang.

Top Research Directions

The 37 research directions with Journal of Cellular and Molecular Medicine 2023 papers, ranked by paper count, next to 2022. Share is the fraction of the edition’s papers in the direction.

#Direction20232022Share 2023Share 20222022 rank
1Integrated mRNA and Protein Quantification for Pathway Mapping2122.2%14.3%7
2Quantifying Cellular Motility and Invasion In Vitro2022.2%0.0%—
3Reversing the Mesenchymal Phenotype to Suppress Metastasis2022.2%0.0%—
4Selective Gene Knockdown Using Small Interfering RNAs2122.2%14.3%19
5Bidirectional Functional Validation of Gene Expression in Disease Models1011.1%0.0%—
6Cellular Identity Transitions in Chronic Tissue Fibrosis1011.1%0.0%—
7Characterizing Atherosclerotic Plaque Vulnerability Beyond Lumen Stenosis1011.1%0.0%—
8Composite Multi-Marker Diagnostic Panels1011.1%0.0%—
9Computational Frameworks for Drug Repurposing1011.1%0.0%—
10Electrophysiological Measurement of Ion Channel Currents1011.1%0.0%—
11Generalizability of In Vitro Findings to In Vivo Systems1011.1%0.0%—
12Identifying Independent Risk Factors with Multivariable Logistic Regression1011.1%0.0%—
13In Vivo Xenograft Models for Preclinical Cancer Research1011.1%0.0%—
14Inhibiting Fibroblast Activation and Extracellular Matrix Accumulation1011.1%0.0%—
15Mapping Immune Landscapes with Multi-Parameter Flow Cytometry1011.1%0.0%—
16Molecular Cascades Driving Cancer Metastasis1011.1%0.0%—
17Molecular Mechanisms of the Maternal to Zygotic Transition1011.1%0.0%—
18Monitoring Autophagic Flux with Tandem Fluorescent Reporters1011.1%0.0%—
19Multicellular Ecosystems and Ecotypes in the Tumor Microenvironment1011.1%0.0%—
20Novel Therapeutic Strategies for Advanced Gastrointestinal Cancers1011.1%0.0%—
21Optimizing Dosing and Sequencing for Synergistic Combination Therapies1011.1%0.0%—
22Principles of Protein Expression Analysis via Western Blotting1111.1%14.3%15
23Prognostic Value Assessment via Cancer Survival Analysis1011.1%0.0%—
24Quantifying Apoptosis Stages via Flow Cytometry1011.1%0.0%—
25Quantifying Cell Viability via Metabolic Activity Assays1011.1%0.0%—

Download all directions as CSV

Institutions

Institutions credited by Journal of Cellular and Molecular Medicine 2023 papers: a paper credits every institution named in its affiliations, once. 26 institutions share 9 credited papers.

#InstitutionPapersShare20222022 rank
100458wv14 111.1%0—
200g5b0g93 111.1%0—
301jbc0c43 111.1%0—
401mtxmr84 111.1%0—
501v11cc68 111.1%0—
6027pr6c67 111.1%0—
702vg7mz57 111.1%0—
8032p70522 111.1%0—
9033nbnf69 111.1%0—
1003ekhbz91 111.1%111
11041rdq190 111.1%0—
1205b59jv37 111.1%0—
13China Medical University 111.1%110
14Columbia University 111.1%0—
15Inner Mongolia University 111.1%0—
16Istanbul University 111.1%0—
17Jilin University 111.1%0—
18Kunming Medical University 111.1%0—
19Nankai University 111.1%0—
20Near East University 111.1%0—
21Shenzhen Second People's Hospital 111.1%0—
22Shenzhen University 111.1%0—
23Tongji University 111.1%0—
24United Nations 111.1%0—
25Wenzhou Medical University 111.1%0—
26Wuhan University 111.1%0—

Download all institutions as CSV

About this data

Papers. Journal of Cellular and Molecular Medicine 2023 lists 9 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2022 use shares, since the edition went from 7 to 9 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 9 of 9 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Journal of Cellular and Molecular Medicine 2023”, https://lacuna.tiptreesystems.com/venue/journal-of-cellular-and-molecular-medicine/2023.

Top Authors

AuthorPapers
Mo Li1

Impactful Papers

Papers from Journal of Cellular and Molecular Medicine 2023 that shaped research clusters.

Influential

Papers

Title
A novel antimicrobial peptide <scp>M1</scp>‐8 targets the lysosomal pathway to inhibit autolysosome formation and promote apoptosis in liver cancer cells
Duvelisib attenuates bleomycin‐induced pulmonary fibrosis via inhibiting the <scp>PI</scp>3<scp>K</scp>/Akt/m<scp>TOR</scp> signalling pathway
Emetine dihydrochloride alleviated radiation‐induced lung injury through inhibiting EMT
Gαi2 regulates the adult myogenesis of masticatory muscle satellite cells
Ion channels and transporters regulate nutrient absorption in health and disease
Melatonin regulates cancer migration and stemness and enhances the anti‐tumour effect of cisplatin
<scp>FLRT2</scp> suppresses bladder cancer progression through inducing ferroptosis
<scp>WHSC1</scp> is involved in <scp>DNA</scp> damage, cellular senescence and immune response in hepatocellular carcinoma progression
Severity of coronary artery disease is associated with diminished <scp>circANRIL</scp> expression: A possible blood based transcriptional biomarker in East Africa